Kennedy Wilson, the Beverly Hills-based real estate investment company, is set to exit the public markets in a management- and Fairfax-backed deal that values the business at roughly $1.65 billion. In an agreement announced Tuesday, Feb. 17, 2026, a consortium led by Chairman and CEO William McMorrow will pay $10.90 per share in cash, with management slated to keep running the company after the transaction closes. The board signed off on the merger following a unanimous recommendation from a special committee, and the parties expect to wrap up the sale in the second quarter of 2026, pending shareholder and regulatory approvals.
Deal Terms and Who Is Funding It
According to a joint press release from Kennedy Wilson, the consortium will buy all outstanding common shares that it does not already own for $10.90 a share. Fairfax has committed up to $1.65 billion of equity to cover the cash consideration, preferred redemptions, and related payments. The companies say the per-share price reflects a 46% premium to an unaffected Nov. 4, 2025, reference price, and the deal is not subject to a financing condition. Management and certain affiliates will roll a portion of their existing equity into the buyer’s ownership structure, keeping them invested in the post-deal company.
Regulatory Filings and Expected Timeline
Per the company’s Form 8-K filing, as posted on StockTitan, the merger agreement was signed on Feb. 16, 2026 and lays out a path that includes stockholder votes and required regulatory clearances before closing. That filing, along with a related Schedule 13D/A, notes that voting and support agreements are already in place and states that Kennedy Wilson’s common shares will be deregistered and will stop trading on the NYSE once the deal is complete. The merger documents spell out customary closing conditions and include an outside date for the transaction if those conditions are not satisfied in time.
Who’s Advising Whom
The deal team is already stacked. Moelis & Company is advising the special committee, while BofA Securities and J.P. Morgan are advising the consortium, according to reporting first published by Connect CRE. On the legal side, Debevoise & Plimpton is counsel to the buyers. Cravath is serving as legal advisor to the special committee, Allen & Overy is counsel to Fairfax, and Latham & Watkins and Ropes & Gray are advising Kennedy Wilson.
What Investors Are Staring At
The $10.90-per-share cash price implies roughly $1.65 billion in value for the shares not already held by the consortium and marks a steep premium to recent trading levels, a point flagged in multiple market writeups after the announcement. Investors pushed Kennedy Wilson’s stock higher on the news, and analysts have called out the deal’s mix of rolled management equity and Fairfax’s expected majority economic interest, as reported by Investing.com. If completed, the transaction will take a familiar REIT name off the public markets and concentrate control with the existing leadership team and Fairfax.
Legal Wrinkles and Governance Watchpoints
The deal is management-led and built around voting agreements, rollover arrangements and a break-fee setup that could make it harder for any rival bidder to break in, according to StockTitan summaries of the Schedule 13D/A and 8-K. Those filings detail how preferred shares will be treated, how the rollover mechanics work and a termination fee of roughly $42.7 million in specified scenarios. They also note that the company and the buyer group intend to file a Schedule 13E-3 and a definitive proxy statement ahead of the stockholder vote. That forthcoming SEC paperwork is expected to be the main public window into the full economic and governance structure of the deal as it moves toward shareholder approval.
